Media coverage about Cemex SAB de CV (NYSE:CX) has trended somewhat positive on Monday, Accern Sentiment reports. The research group identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Cemex SAB de CV earned a daily sentiment score of 0.11 on Accern’s scale. Accern also gave news stories about the construction company an impact score of 45.4732731121646 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
These are some of the news stories that may have effected Accern’s scoring:
- CX INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of CEMEX, S.A.B. de C.V. Investors (finance.yahoo.com)
- Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Cemex, S.A.B. de C.V. (CX) and Encourages Investors to Contact the Firm (finance.yahoo.com)
- Notable Trader’s Watch List: IHS Markit Ltd., (NASDAQ: INFO), CEMEX, SAB de CV, (NYSE: CX) – Global Export Lines (press release) (globalexportlines.com)
- CEMEX, SAB de CV (CX) estimated to achieve EPS growth of 37.50% for this year – Wallstreet Investorplace (wallstreetinvestorplace.com)
- Hot Stock under Review – CEMEX SAB de CV (NYSE: CX) – Stocks Pen (stockspen.com)
Cemex SAB de CV stock traded down $0.18 during midday trading on Monday, reaching $6.76. The company’s stock had a trading volume of 8,863,937 shares, compared to its average volume of 10,891,191. The stock has a market cap of $10,134.26, a PE ratio of 12.27, a PEG ratio of 0.65 and a beta of 1.48. Cemex SAB de CV has a 52-week low of $6.45 and a 52-week high of $10.37. The company has a debt-to-equity ratio of 0.84, a quick ratio of 0.47 and a current ratio of 0.64.
A number of brokerages have recently issued reports on CX. Bank of America decreased their target price on Cemex SAB de CV from $8.70 to $8.00 and set a “neutral” rating for the company in a report on Monday, March 5th. Zacks Investment Research cut Cemex SAB de CV from a “hold” rating to a “sell” rating in a report on Tuesday, December 19th. JPMorgan Chase & Co. reiterated an “overweight” rating and set a $10.00 target price (down previously from $10.60) on shares of Cemex SAB de CV in a report on Wednesday, March 14th. UBS cut Cemex SAB de CV from a “buy” rating to a “sell” rating and decreased their target price for the stock from $7.62 to $6.50 in a report on Thursday, February 15th. Finally, ValuEngine cut Cemex SAB de CV from a “buy” rating to a “hold” rating in a report on Friday, December 1st. One analyst has rated the stock with a sell rating, six have assigned a hold rating and five have given a buy rating to the stock. Cemex SAB de CV has a consensus rating of “Hold” and an average target price of $9.49.
COPYRIGHT VIOLATION WARNING: “Cemex SAB de CV (CX) Given Daily News Sentiment Rating of 0.11” was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this article on another website, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The legal version of this article can be accessed at https://stocknewstimes.com/2018/03/19/cemex-sab-de-cv-cx-given-daily-news-sentiment-rating-of-0-11.html.
Cemex SAB de CV Company Profile
CEMEX, SAB. de C.V. (CEMEX) is an operating and holding company engaged, directly or indirectly, through its operating subsidiaries, primarily in the production, distribution, marketing and sale of cement, ready-mix concrete, aggregates, clinker and other construction materials throughout the world, and that provides construction-related services to customers and communities in over 50 countries throughout the world.
Receive News & Ratings for Cemex SAB de CV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cemex SAB de CV and related companies with MarketBeat.com's FREE daily email newsletter.